tetano
Editor, Senior Moderator
Emerg Microbes Infect
. 2026 Dec;15(1):2610856.
doi: 10.1080/22221751.2025.2610856. Epub 2026 Jan 21.
Broad cross-T cell immunity between emerging SARS-CoV-2 serotypes waved by spike-signature mutations
Yuanyuan Guo[SUP] 1 2 [/SUP], Jinmin Tian[SUP] 3 2 [/SUP], Peipei Guo[SUP] 1 [/SUP], Xin Wang[SUP] 1 [/SUP], Bingli Shang[SUP] 4 [/SUP], Junying She[SUP] 4 [/SUP], Mengjie Yang[SUP] 5 [/SUP], George F Gao[SUP] 1 3 4 6 [/SUP], Jun Liu[SUP] 3 4 2 [/SUP]
Affiliations
Since its emergence in late 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has continuously threatened human health through constantly arising variants with iterative immune escape abilities. While SARS-CoV-2 variants have been recently classified into six serotypes based on cross-reactive antibody responses, T cell response features against these serotypes remain largely unknown. We evaluated SARS-CoV-2 spike-specific T cell responses among convalescents infected by three different strains (prototype, BA.5.2/BF.7, and XBB/EG.5.1) against SARS-CoV-2 prototype and 15 subvariants covering all six serotypes. Generally, cross-reactive T cells could recognize variants within the same serotype, but they also mounted weaker responses to variants from subsequent serotypes. Serotype I (prototype) convalescents showed lower T cell responses against Omicron variants (Serotype II to IV), with cross-reactive T cell gaps between different serotype strains, i.e. Serotype II > III > IV. Serotype IV (BA.5.2/BF.7) convalescents exhibited weaker T cell responses to Serotype V (XBB/XBB.1.5/XBB.1.16/EG.5.1) strains and even lower responses to Serotype VI (BA.2.86/JN.1) strains. Similarly, Serotype V (XBB) convalescents showed significantly weaker cross-T cell responses to the Serotype VI (BA.2.86) strains than to the Serotype V strains. We also identified key serotype-signature mutations in T cell epitope hotspot regions that could attenuate CD8[SUP]+[/SUP] and/or CD4[SUP]+[/SUP] T cell recognition, potentially underlying SARS-CoV-2 serotype-associated T cell immune evasion mechanisms. Our findings reveal the pivotal role of population T cell immune barrier against emerging SARS-CoV-2 variants in a serotype-associated pattern and provide insights into the T cell-oriented universal vaccine development for coronaviruses.
Keywords: Omicron; SARS-CoV-2; T cell immunity; cross-reactive; epitope hotspot; serotype.
. 2026 Dec;15(1):2610856.
doi: 10.1080/22221751.2025.2610856. Epub 2026 Jan 21.
Broad cross-T cell immunity between emerging SARS-CoV-2 serotypes waved by spike-signature mutations
Yuanyuan Guo[SUP] 1 2 [/SUP], Jinmin Tian[SUP] 3 2 [/SUP], Peipei Guo[SUP] 1 [/SUP], Xin Wang[SUP] 1 [/SUP], Bingli Shang[SUP] 4 [/SUP], Junying She[SUP] 4 [/SUP], Mengjie Yang[SUP] 5 [/SUP], George F Gao[SUP] 1 3 4 6 [/SUP], Jun Liu[SUP] 3 4 2 [/SUP]
Affiliations
- PMID: 41566607
- PMCID: PMC12829424
- DOI: 10.1080/22221751.2025.2610856
Since its emergence in late 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has continuously threatened human health through constantly arising variants with iterative immune escape abilities. While SARS-CoV-2 variants have been recently classified into six serotypes based on cross-reactive antibody responses, T cell response features against these serotypes remain largely unknown. We evaluated SARS-CoV-2 spike-specific T cell responses among convalescents infected by three different strains (prototype, BA.5.2/BF.7, and XBB/EG.5.1) against SARS-CoV-2 prototype and 15 subvariants covering all six serotypes. Generally, cross-reactive T cells could recognize variants within the same serotype, but they also mounted weaker responses to variants from subsequent serotypes. Serotype I (prototype) convalescents showed lower T cell responses against Omicron variants (Serotype II to IV), with cross-reactive T cell gaps between different serotype strains, i.e. Serotype II > III > IV. Serotype IV (BA.5.2/BF.7) convalescents exhibited weaker T cell responses to Serotype V (XBB/XBB.1.5/XBB.1.16/EG.5.1) strains and even lower responses to Serotype VI (BA.2.86/JN.1) strains. Similarly, Serotype V (XBB) convalescents showed significantly weaker cross-T cell responses to the Serotype VI (BA.2.86) strains than to the Serotype V strains. We also identified key serotype-signature mutations in T cell epitope hotspot regions that could attenuate CD8[SUP]+[/SUP] and/or CD4[SUP]+[/SUP] T cell recognition, potentially underlying SARS-CoV-2 serotype-associated T cell immune evasion mechanisms. Our findings reveal the pivotal role of population T cell immune barrier against emerging SARS-CoV-2 variants in a serotype-associated pattern and provide insights into the T cell-oriented universal vaccine development for coronaviruses.
Keywords: Omicron; SARS-CoV-2; T cell immunity; cross-reactive; epitope hotspot; serotype.